Chee, Desmond
84  results:
Search for persons X
?
3

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Respon..:

Chanchlani, Neil ; Lin, Simeng ; Chee, Desmond...
Journal of Crohn's and Colitis.  16 (2021)  3 - p. 389-397 , 2021
 
?
4

Patient-led Remote IntraCapillary pharmacoKinetic Sampling ..:

Chee, Desmond ; Nice, Rachel ; Hamilton, Ben...
Journal of Crohn's and Colitis.  16 (2021)  2 - p. 190-198 , 2021
 
?
7

Real-world Effectiveness of Tofacitinib for Moderate to Sev..:

Honap, Sailish ; Chee, Desmond ; Chapman, Thomas P...
Journal of Crohn's and Colitis.  14 (2020)  10 - p. 1385-1393 , 2020
 
?
 
?
9

Quality improvement project identifies factors associated w..:

Walker, Gareth J. ; Lin, Simeng ; Chanchlani, Neil...
Alimentary Pharmacology & Therapeutics.  52 (2020)  3 - p. 471-480 , 2020
 
?
10

Root‐cause analyses of missed opportunities for the diagnos..:

Gordon, Claire ; Chee, Desmond ; Hamilton, Ben...
Alimentary Pharmacology & Therapeutics.  53 (2020)  2 - p. 291-301 , 2020
 
?
11

Visible age-related signs in an Arab patient presenting wit..:

Nerlekar, Nitesh ; Chee, Desmond ; Narayanasamy, Shanti..
Journal of the Saudi Heart Association.  27 (2015)  2 - p. 135-136 , 2015
 
?
12

Lack of congruence between patients' and health professiona..:

Wu, Simon ; Chee, Desmond ; Ugalde, Anna...
Palliative and Supportive Care.  13 (2014)  2 - p. 255-263 , 2014
 
?
13

The potential of capillary birthmarks as a significant mark..:

Chee, Desmond ; Phillips, Rod ; Maixner, Wirginia..
Journal of Pediatric Surgery.  45 (2010)  12 - p. 2419-2422 , 2010
 
?
14

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Respon..:

Chanchlani, Neil ; Lin, Simeng ; Chee, Desmond...
Chanchlani , N , Lin , S , Chee , D , Hamilton , B , Nice , R , Arkir , Z , Bewshea , C , Cipriano , B , Derikx , L A A P , Dunlop , A , Greathead , L , Griffiths , R L , Ibraheim , H , Kelleher , P , Kok , K B , Lees , C W , MacDonald , J , Sebastian , S , Smith , P J , McDonald , T J , Irving , P M , Powell , N , Kennedy , N A , Goodhand , J R & Ahmad , T 2022 , ' Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses : Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients ' , Journal of Crohn's & colitis , vol. 16 , no. 3 , pp. 389-397 . https://doi.org/10.1093/ecco-jcc/jjab153.  , 2022
 
?
15

Antibody decay, T cell immunity and breakthrough infections..:

Lin, Simeng ; Kennedy, Nicholas A ; Saifuddin, Aamir...
https://discovery.ucl.ac.uk/id/eprint/10147352/1/s41467-022-28517-z.pdf.  , 2022
 
1-15